A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal homeostasis, according to a new study. The findings suggest potential for new treatment strategies. Read more
Medical News - Nov 21
A once-daily pill for ulcerative colitis has delivered strong results in a clinical trial, easing symptoms even in patients for whom other treatments had failed and raising hopes for a safer, more effective therapy for a condition that affects millions.Continue ReadingCategory: Illnesses and cond... Read more
New Atlas - Oct 08
